Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 WuXi PharmaTech | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

WuXi PharmaTech

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Dr. Debra Yu has been appointed vice president of strategy, WuXi PharmaTech. Dr. Yu will be responsible for leading the company’s strategic planning and initiatives. She will report to Dr. Ge Li, chairman and chief executive officer of WuXi PharmaTech.
   
Prior to joining the company, Dr. Yu co-led Pfizer’s venture capital group and was instrumental in working in areas such as diagnostics, asset monetization and creative finance structures and Pfizer’s innovation agenda. Earlier she was a general partner at Delphi Ventures and a managing director at Bay City Capital, two Bay area venture firms focused on the life sciences. Dr. Yu has also held senior positions at many leading companies and organizations like McKinsey & Co., the FDA, the Wilkerson Group, Morgan Stanley & Co., Genentech and the Permanente Co.  
   
“I am very pleased to welcome Debra on board to further increase the depth of our senior management,” commented Dr. Ge Li. “With 19 years of experience in venture capital and life sciences, Debra will provide strategic guidance as we continue building a global drug and medical device R&D service platform through organic growth, partnership and M&A.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters